Tagged immunoassay

• US 4,436,826 A
• Filed: 10/21/1981
• Issued: 03/13/1984
• Est. Priority Date: 10/21/1981
• Status: Expired due to Fees

• Current Assignee: Profile Diagnostic Sciences Incorporated (Penge Corp.)
• Original Assignee: Wang Associates
• Inventors: Wang, Chia-Gee
• Primary Examiner(s): Turk, Arnold
• Application Number:
  US06/313,711
• Time in Patent Office: 874 Days
• Field of Search: 23/230 B, 23/915, 23/920, 424/12, 422/68, 422/73, 250/461 B, 436/533, 436/534, 436/525, 436/526, 436/829
• US Class Current: 436/525
• CPC Class Codes: G01N 33/532 Production of labelled immunochemicals
• CPC Class Codes: Y10S 436/829 Liposomes, e.g. encapsulation

Abstract

An immunoassay method for measurement of the content of a target antigen or antibody in a fluid or tissue specimen comprises reacting the target with reagent antibody or antigen which forms a complex with the target and is tagged with tagging elements which are unassociated chemically with said reagent and are protected against reaction with the target and the biological and chemical environment of the assay. Preferably the reagent antibody or antigen is carried by small, tagged mobile units, such as latex particles of a size smaller than 0.8 μm, having tagging elements embedded therein. The tagged complexes which are formed may be measured by X-ray fluorescence or by detection of radioactive decay. Different target antigens or antibodies can be assayed simultaneously by employing different tagged mobile units, and the mobile units with the tagging elements can be recovered for disposal or for reuse.

Claims

1. An immunoassay method for measurement of the content of a target antigen or antibody in a fluid or tissue specimen, which comprises reacting the target with reagent antibody or antigen which forms a complex with the target and is tagged with tagging elements or compounds which are unassociated chemically with said reagent and are protected against reaction with the target and the biological and chemical environment of the assay, and detecting the formed, tagged complexes.

2. A method according to claim 1, wherein the tagging elements or compounds are protected by being embedded within small latex particles.

3. A method according to claim 2, wherein the tagging elements or compounds were embedded by ion implantation into said latex particles.

4. A method according to claim 2, wherein the tagging elements or compounds were embedded by vapor coating onto a portion of the surface of a latex particle, followed by further coating the vapor coated portion of the latex particle with an element or a compound which is non-reactive with the target and the biological and chemical environment of the assay.

5. A method according to claim 2, wherein the tagging elements or compounds were embedded by coating thin latex sheets with the tagging elements or compounds, pressing the coated surfaces of two sheets together to form a composite sheet and cutting the composite sheet with an electron or ion beam into particles.

6. A method according to claim 2, wherein the small latex particles carry a plurality of reagent antibody or antigen molecules and said particles are sequentially introduced to the specimen for reaction with the target antigen or antibody.

7. A method according to claim 2, wherein the small latex particles carry a plurality of reagent antibody or antigen molecules and said particles are introduced to the specimen in small increments for reaction with the target antigen or antibody.

8. A method according to claim 1, wherein the reagent antibody or antigen is tagged with heavy tagging elements which have an atomic weight in excess of 50.

9. A method according to claim 1, wherein the tagged complexes are detected by X-ray fluorescence.

10. An immunoassay method for measurement of the content of a target antigen or antibody in a fluid or tissue specimen, which comprises reacting the target with reagent antibody or antigen which forms a complex with the target and is carried by small tagged mobile units having tagging elements or compounds which are unassociated chemically with said reagent and are protected against reaction with the target and the biological and chemical environment of the assay, and detecting the tagged mobile units bearing formed complexes.

11. A method according to claim 10, wherein the tagged mobile units are smaller than 0.8 μ

m.

12. A method according to claim 10, wherein the tagged mobile units are smaller than 0.35 μ

m.

13. A method according to claim 10, wherein the tagged mobile units are smaller than 0.1 μ

m.

14. A method according to claim 10, wherein the mobile units have a size in the range from 0.1 μ

m to 0.008 μ

m.

15. A method according to claim 10, 12 or 13, wherein said mobile units are latex particles.

16. A method according to claim 15, wherein the tagging elements or compounds are protected by being embedded within said latex particles.

17. A method according to claim 16, wherein the tagging elements or compounds were embedded by ion implantation into said latex particles.

18. A method according to claim 16, wherein the tagging elements or compounds were embedded by vapor coating onto a portion of the surface of a latex particle, followed by further coating the vapor coated portion of the latex particle, with an element or a compound which is non-reactive with the target and the biological and chemical environment of the assay.

19. A method according to claim 16, wherein the tagging elements or compounds were embedded by coating thin latex sheets with the tagging elements or compounds, pressing the coated surfaces of two sheets together to form a composite sheet, and cutting the composite sheet with an electron or ion beam into particles.

20. A method according to claim 10, wherein the reagent antibody or antigen is tagged with heavy tagging elements which have an atomic weight in excess of 50.

21. A method according to claim 10, wherein the tagged mobile units carrying reagent antibody or antigen are sequentially introduced to the specimen for reaction with the target antigen or antibody.

22. A method according to claim 10, wherein the tagged mobile units carrying reagent antibody or antigen are introduced to the specimen in small increments for reaction with the target antigen or antibody.

23. A method according to claim 10, wherein the tagged complexes are detected by X-ray fluorescence.

24. An immunoassay method for measurement of the content of a target antigen or antibody in a fluid or tissue specimen, which comprises coupling reagent antibody or antigen, which forms a complex with the target, with small tagged mobile units having tagging elements or compounds which are unassociated chemically with said reagent and are protected against reaction with the target and the biological and chemical environment of the assay, reacting the tagged mobile units coupled with antibody or antigen with the target antigen or antibody, separating the unreacted mobile units and measuring the number of reacted mobile units by detection of the tagging elements or compounds.

25. A method according to claim 24, wherein the tagged mobile units are smaller than 0.8 μ

m.

26. A method according to claim 24, wherein the tagged mobile units are smaller than 0.35 μ

m.

27. A method according to claim 24, wherein the tagged mobile units are smaller than 0.1 μ

m.

28. A method according to claim 24, wherein the mobile units have a size in the range from 0.1 μ

m to 0.008 μ

m.

29. A method according to claim 24, 26 or 27, wherein said mobile units are latex particles.

30. A method according to claim 24, wherein the tagging elements or compounds are protected by being embedded within said latex particles.

31. A method according to claim 30, wherein the latex is polystyrene.

32. A method according to claim 30, wherein the tagging elements or compounds were embedded by ion implantation into said latex particles.

33. A method according to claim 30, wherein the tagging elements of compounds were embedded by vapor coating onto a portion of the surface of a latex particle, followed by further coating the vapor coated portion of the latex particle with an element or a compound which is non-reactive with the target and the biological and chemical environment of the assay.

34. A method according to claim 30, wherein the tagging elements or compounds were embedded by coating thin latex sheets with the tagging elements or compounds, pressing the coated surfaces of two sheets together to form a composite sheet and cutting the composite sheet with an electron or ion beam into particles.

35. A method according to claim 24, wherein the reagent antibody or antigen is tagged with heavy tagging elements which have an atomic weight in excess of 50.

36. A method according to claim 24, wherein the tagged mobile units carrying reagent antibody or antigen are sequentially introduced to the specimen for reaction with the target antigen or antibody.

37. A method according to claim 24, wherein the tagged mobile units carrying reagent antibody or antigen are introduced to the specimen in small increments for reaction with the target antigen or antibody.

38. A method according to claim 24, wherein undesired agglutinator compounds are removed from the fluid or tissue containing target antigen or antibody before the reaction with tagged mobile units coupled with antibody or antigen.

39. A method according to claim 38, wherein said agglutinator compounds are removed by contacting them with activated antibody conjugated to a latex matrix.

40. A method according to claim 24, wherein said unreacted mobile units are separated by contacting the fluid or tissue with added antigen or antibody which is the same as the target antigen or antibody and is conjugated to a solid phase matrix, incubating for a short time, and separating said fluid or tissue from said solid phase matrix.

41. A method according to claim 24, wherein after said separation of unreacted mobile units the remaining reacted mobile units are concentrated or agglutinated prior to detection of the tagging elements or compounds.

42. A method according to claim 24, wherein the tagging elements of the reacted mobile units are measured by X-ray fluorescence.

43. A method according to claim 24, wherein the tagging elements are radioactive and the number of reacted mobile units it measured by detection of radioactivity.

44. A method according to claim 42, wherein the measurement is compared with a calibration curve of known target antigen or antibody concentration plotted against X-ray fluorescence measurement.

45. A method according to claim 42 of 43, wherein after the measurement the reacted mobile units are recovered for disposal or reprocessing for reuse.

46. A method according to claim 24, wherein the contents of different target antigens or antibodies in said fluid or tissue are simultaneously measured by reacting with each different target tagged mobile units which have tagging elements or compounds specific to each target and which are coupled with antibody or antigen specific to each target, and measuring the number of reacted mobile units of each different complex in the same fluid or tissue specimen by detection of the different X-ray fluorescence of each different tagging element.